Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Singular Genomics is a biotech company focused on delivering genomic technologies for the advancement of science and medicine.
We help healthcare reduce risk & cost by monitoring, managing and engaging patients at home.
C2i Genomics provides cloud-based cancer diagnostic services to pharmaceutical and diagnostic organizations.
Metromile is a car insurance company using data science and machine learning to offer drivers new and fairer insurance.
XOKind is an AI startup, formed with the mission of simplifying human planning and decision.
BloomAPI is a way to easily collect medical data and present it in any setting it's needed.
S32 has invested in 102 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
S32's top investment sectors include Health Care, Medical, Machine Learning, Biotechnology, Home Health Care. The firm invests across 16 different industry categories.
Among tracked funding rounds, Metromile received $170.0M in a Post Ipo Equity round. S32's total known invested capital is $4.1B.
S32's average investment size is $57.3M across its portfolio of 102 companies.
Recent S32 portfolio additions include Singular Genomics, Current Health, C2i Genomics, Metromile. These companies were founded in 2020 or later.